Overtime pay lawsuits are a big topic at LawyersAndSettlements.com—we report a lot on unpaid overtime settlements. So much, in fact, that it can take some effort to keep track of it all. Case in point, our recent post on 61 companies that have had overtime lawsuits; the post was only about overtime pay and it only listed a handful of ’em.
That’s when the recent developments at Wet Seal caught my eye. You’ve probably passed a Wet Seal in the shopping mall—or perhaps you even shop there. You can even get the t-shirt shown here at Wet Seal, and you’ve got to appreciate the irony on that one (btw, for those who care, it’s currently $9.90, BOGO 50% off). They’re all about the teen and twenty-something set, which is basically what their on-the-floor labor force is about as well.
Young though they may be, they’re apparently no fools, and some have gone after Wet Seal for Read the rest of this entry »
The Avandia/Actos battle has been making headlines since August 19 (BMJ.com) when a Canadian researcher suggested the oral diabetes treatment Actos is safer than Avandia. (Coincidentally, Takeda Canada announced a few days later that it reacquired the Canadian marketing rights for its Actos from Eli Lilly’s Canadian company. The drugmaker licensed the rights to Lilly under a worldwide agreement in 1999—financial arrangements were not disclosed.)
The similarities: Both Avandia and Actos belong to a class of drugs called thiazolidinediones, which are used widely to lower blood sugar in people with type 2 diabetes. In addition to an increased risk for heart failure, both drugs can also cause side effects that include weight gain and fluid retention. Both medications carry a U.S. Food and Drug Administration warning and both meds run the same risk of heart attack.
The discrepancies: Researchers found that patients taking Avandia were at greater risk of Read the rest of this entry »
Here’s the question…
Some new federal regulations are in the pipeline for cigarette packs—graphic (and disturbing) pictures of what smoking can do to a body. Images of things like of throat cancer tumors…seriously discolored and decayed teeth…blackened lungs…tracheotomies. Apparently our friends north of the border already have similar programs in place and it’s been reported that these tactics actually work to deter folks from continuing the habit (healthfinder.gov 8/27/09).
The regulations would actually be part of the legislation that President Obama signed back in June with the Family Smoking Prevention and Tobacco Control Act. The legislation gives the FDA authority to regulate how tobacco products are marketed.
Now, I don’t defend tobacco companies—but seriously. When and where do we draw the line on Read the rest of this entry »
So we just posted about Kerry Sims, the woman who’s recently filed a lawsuit against Bayer’s Yaz birth control pills. Ms. Sims alleges she suffered a blood clot in her lung and an infection surrounding the clot while on Yaz.
But here’s the interesting twist—the one that brings “shotgun style” to mind. In true git ’em all fashion, she’s not just suing Bayer, the maker of Yaz and Yasmin oral contraceptives, she’s also naming Walgreen’s in her suit. As reported in the Madison Record yesterday,
“In selling, Yaz/Yasmin to plaintiff, Walgreens expressly and impliedly warranted that Yaz/Yasmin was safe for its intended use, was free from manufacturing or production defects, and would perform as indicated,” Sims’s suit states.
While this is not unusual practice—i.e., to include other seemingly uninvolved or not-at-fault parties into a lawsuit—it does paint an interesting picture when the focus of the lawsuit is Read the rest of this entry »
Another young woman has suffered a blood clot while using Yaz/Yasmin.
She is alive. Thankfully.
And apparently once she put two and two together, she got pissed off enough that she’s now suing Bayer.
Kerry Sims was prescribed Yasmin for birth control. She alleges she suffered a blood clot in her lung and an infection surrounding the clot while on the pill. The complaint reportedly alleges that between 2004 and 2008 Yaz caused in excess of 50 deaths in women taking the pill, some as young as 17. Sims maintains that had she known the risks associated with Yaz/Yasmin she would not have taken it. Those “risks” refer to the likelihood of deep vein thrombosis (DVT); pulmonary embolism (PE); gallbladder complications and gallbladder disease; stroke; heart attack and death.